Cellect Biotechnology Ltd.

2.59-0.2000-7.17%Vol 209.18K1Y Perf 28.49%
Apr 13th, 2021 15:18 DELAYED
BID2.57 ASK2.59
Open2.74 Previous Close2.79
Pre-Market- After-Market-
 - -%  - -
Target Price
12.00 
Analyst Rating
— 0.00
Potential %
366.93 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap5.80M 
Earnings Rating
Neutral
Price Range Ratio 52W %
17.09 
Earnings Date
20th May 2021

Today's Price Range

2.552.78

52W Range

1.657.15

5 Year PE Ratio Range

-3.40-3.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-4.12%
1 Month
-27.72%
3 Months
4.89%
6 Months
26.24%
1 Year
28.49%
3 Years
-92.02%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
APOP2.59-0.2000-7.17
AAPL134.473.23002.46
GOOG2 275.3820.59000.91
MSFT258.522.61001.02
XOM55.780.28000.50
WFC39.90-0.8700-2.13
JNJ159.84-1.8000-1.11
FB311.37-0.1700-0.05
GE13.50-0.0900-0.66
JPM154.75-1.2000-0.77
Earnings HistoryEstimateReportedSurprise %
Q03 2020--0.12-
Q02 2020--0.69-
Q01 2020--0.22-
Q04 2019--0.77-
Q03 2019--0.61-
Q02 2019--0.02-
Q01 2019--0.16-
Q04 2018--0.16-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.36-24.14Negative
12/2018 FY-1.07-9.18Negative
3/2019 QR-0.33-6.45Negative
12/2019 FY-1.228.27Positive
Next Report Date20th May 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume209.18K
Shares Outstanding2.24M
Trades Count859
Dollar Volume441.23K
Avg. Volume1.82M
Avg. Weekly Volume228.37K
Avg. Monthly Volume5.78M
Avg. Quarterly Volume2.04M

Cellect Biotechnology Ltd. (NASDAQ: APOP) stock closed at 2.79 per share at the end of the most recent trading day (a -4.45% change compared to the prior day closing price) with a volume of 183.81K shares and market capitalization of 5.80M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 14 people. Cellect Biotechnology Ltd. CEO is Shai Yarkoni.

The one-year performance of Cellect Biotechnology Ltd. stock is 28.49%, while year-to-date (YTD) performance is 29.17%. APOP stock has a five-year performance of %. Its 52-week range is between 1.65 and 7.15, which gives APOP stock a 52-week price range ratio of 17.09%

Cellect Biotechnology Ltd. currently has a PE ratio of -1.90, a price-to-book (PB) ratio of 2.62, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -87.78%, a ROC of -93.39% and a ROE of -120.45%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Cellect Biotechnology Ltd., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Cellect Biotechnology Ltd.’s next earnings report date is 20th May 2021.

The consensus rating of Wall Street analysts for Cellect Biotechnology Ltd. is (0), with a target price of $12, which is +366.93% compared to the current price. The earnings rating for Cellect Biotechnology Ltd. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cellect Biotechnology Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cellect Biotechnology Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.34, ATR14 : 0.37, CCI20 : -101.93, Chaikin Money Flow : -0.89, MACD : -0.09, Money Flow Index : 95.18, ROC : -20.06, RSI : 46.04, STOCH (14,3) : 0.91, STOCH RSI : 0.54, UO : 40.41, Williams %R : -99.09), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cellect Biotechnology Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd is a biotechnology company that has developed a novel technology platform known as ApoGraft that functionally selects cells in order to improve the safety and efficacy of regenerative medicine and cell therapies. The company is developing its first product based on its ApoGraft technology platform, the ApoTainer kit that utilizes FasL- apoptotic protein.

CEO: Shai Yarkoni

Telephone: +972 99741444

Address: 23 Hata'as Street, Kfar Saba 44425, , IL

Number of employees: 14

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

59%41%

Bearish Bullish

48%52%

News

Stocktwits